CV CapsoVision, Inc.

NASDAQ
$6.65

CapsoVision, Inc. (CV) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.12 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.6% since its last earnings release on November 12, 2026.

CapsoVision Reported In-line with Estimates
Thursday, November 12, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.12)
Rev est $4.5M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.38

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CapsoVision, Inc.

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and screening of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval.

Sector

Healthcare

Industry

Healthcare Info Services

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.